Simvastatin, marketed under the trade name Zocor among others, is a lipid-lowering medication. It is used along with exercise, diet, and weight loss to decrease elevated lipid (fat) levels. It is also used to decrease the risk of heart problems in those at high risk. It is taken by mouth.

The global Simvastatin Drug market was valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025.
This report focuses on Simvastatin Drug volume and value at global level, regional level and company level. From a global perspective, this report represents overall Simvastatin Drug market size by analyzing historical data and future prospect.
Regionally, this report categorizes the production, apparent consumption, export and import of Simvastatin Drug in North America, Europe, China, Japan, Southeast Asia and India.
For each manufacturer covered, this report analyzes their Simvastatin Drug manufacturing sites, capacity, production, ex-factory price, revenue and market share in global market.

The following manufacturers are covered:
Merck
Salerno Pharma
Teva Pharmaceutical
Aurobindo Pharma
Dr. Reddy's Laboratories
Zydus Pharmaceuticals
Biocon
Lupin Pharmaceuticals
Accord Healthcare
Mylan

Segment by Regions
North America
Europe
China
Japan
Southeast Asia
India

Segment by Type
5mg
10mg
20mg
40mg
80mg

Segment by Application
Adult
Children(10-17 years)